The Metabolomic View of Systemic Sclerosis—A Systematic Literature Review
The mortality risk in systemic sclerosis (SSc) is primarily determined by pulmonary involvement (interstitial lung disease (ILD), pulmonary fibrosis), pulmonary arterial hypertension (PAH), and cardiac involvement. With timely and intensive treatment, the disease can be halted or even improved. Ther...
Saved in:
Main Authors: | Sebastian T. Jendrek, Franziska Schmelter, Christian Sina, Ulrich L. Günther, Gabriela Riemekasten |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2025-05-01
|
Series: | Sclerosis |
Subjects: | |
Online Access: | https://www.mdpi.com/2813-3064/3/2/18 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Overview of metabolomic markers used for diagnosing cardiovascular diseases
by: O. V. Astafyeva, et al.
Published: (2022-02-01) -
Untargeted metabolomics revealed urinary metabolic pattern for discriminating prostate cancer from benign prostatic hyperplasia in Chinese participants
by: Chenye Tang, et al.
Published: (2025-06-01) -
Metabolomics in Breast Cancer: From Biomarker Discovery to Personalized Medicine
by: Rosa Perestrelo, et al.
Published: (2025-06-01) -
Urine metabolomic characteristics of people exposed to hexavalent chromium in drinking water
by: Tao Yanan, et al.
Published: (2025-09-01) -
Determination of Biochemical and Metabolomic Characteristics of Sheep Blood Serum and Their Application in Clinical Practice
by: Peter Očenáš, et al.
Published: (2025-07-01)